NIM
AGN

Northeast Investment Management’s Allergan Inc AGN Stock Holding History

Northeast Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,729
Closed -$793K – 173
2014
Q4 		$793K Sell
3,729
-63
-2% -$12.5K 0.08% 113
2014
Q3 		$676K Sell
3,792
-82
-2% -$13.6K 0.07% 118
2014
Q2 		$656K Sell
3,874
-363
-9% -$56.5K 0.07% 118
2014
Q1 		$526K Sell
4,237
-2,104
-33% -$256K 0.06% 123
2013
Q4 		$704K Sell
6,341
-28,154
-82% -$2.69M 0.08% 108
2013
Q3 		$3.12M Sell
34,495
-13,873
-29% -$1.25M 0.38% 64
2013
Q2 		$4.08M Buy
+48,368
New +$5.02M 0.52% 58

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Northeast Investment Management's AGN Position: Q1 2015 in Review

Northeast Investment Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 3,729 shares — an estimated $793K sold.

Northeast Investment Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $4.08M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Northeast Investment Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Northeast Investment Management sold 3,729 Allergan Inc shares in Q1 2015, an estimated $793K.
  • Northeast Investment Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Northeast Investment Management's Allergan Inc position peaked at $4.08M in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Northeast Investment Management's 13F filing for Q1 2015, filed 12 May 2015.